INVESTABOT
Equity Research
XNYS · LABORATORY ANALYTICAL INSTRUMENTS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Avantor posted Q1 2026 net sales of $1.58 billion with net income of $43.3 million, down from $64.5 million in the same quarter last year. The headline number masks a currency story: flat reported revenue…
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 0 unique sellers · 7 accumulating - 4 trimming - 0 unchanged
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 44,007,348 | ~$933.0M | — | August 13, 2024 |
| Vanguard Group | 64,904,889 | ~$743.8M | — | January 29, 2026 |
| BlackRock | 70,281,231 | ~$695.8M | 7.0% | August 7, 2026 |
| BlackRock | 59,596,926 | ~$683.0M | — | February 12, 2026 |
| BlackRock | 65,703,554 | ~$515.1M | 10.3% | May 13, 2026 |
| State Street | 20,209,406 | ~$231.6M | — | February 13, 2026 |
| State Street | 21,572,974 | ~$213.6M | 4.1% | August 7, 2026 |
| Morgan Stanley | 17,468,418 | ~$200.2M | — | May 27, 2026 |
| State Street | 20,721,079 | ~$162.5M | 2.5% | May 15, 2026 |
| AQR Capital | 11,627,566 | ~$115.1M | 138.9% | August 14, 2026 |
| DE Shaw | 13,110,674 | ~$102.8M | 110.9% | May 15, 2026 |
| DE Shaw | 9,571,523 | ~$94.8M | -27.0% | August 14, 2026 |
| Fidelity (FMR) | 7,670,732 | ~$87.9M | — | February 17, 2026 |
| Fidelity (FMR) | 7,845,462 | ~$77.7M | 3.1% | August 13, 2026 |
| DE Shaw | 6,215,923 | ~$71.2M | — | February 17, 2026 |
| Morgan Stanley | 6,758,161 | ~$66.9M | 10.8% | August 13, 2026 |
| Goldman Sachs | 6,204,341 | ~$61.4M | 65.3% | August 14, 2026 |
| Fidelity (FMR) | 7,610,318 | ~$59.7M | -0.8% | May 15, 2026 |
| AQR Capital | 4,391,597 | ~$50.3M | — | February 17, 2026 |
| Morgan Stanley | 6,098,287 | ~$47.8M | -65.1% | May 15, 2026 |